Answers are grounded in this paper and cite their sources.
between 2 or more treatments should be considered equivalent.We chose the 0.75 clinical severity rating margin as our criterion for equivalence based on our previous studies examining the Unified Protocol 5 as this margin would require the point estimate and the entire confidence interval of the Unified Protocol vs single-order protocols effect size to be less than a small to medium effect size and clinically nonsignificant.Third, power calculations were performed using SAS PROC POWER (SAS Institute Inc) for all stated primary aims.Fourth, our prespecified plan for evaluating the principal hypothesis of equivalence used confidence intervals of the slope difference scores from latent growth models.Although our findings supported equivalence, we still reported effect sizes with 95% confidence intervals for between-condition comparisons on our primary and secondary outcomes, which, as can be seen in Table 3 of our article, 1 were all small in magnitude and not statistically significant at both posttreatment and follow-up.To address points 5 and 6, as noted in the article, 1 3 of the 4 criterion standard single-disorder protocols, as well as the Unified Protocol, were developed in our center and have been in daily use for years.Although training and supervision in all treatment protocols was provided at our center, initial certification and ongoing ratings of adherence and competence for each individual single-disorder protocol were established by an external team of raters known for their expertise with the relevant single-disorder protocol.These raters, of course, were not blinded to what they were rating.Outcome measures, on the other hand, were rated by blinded independent evaluators.We also note in the article the importance of replicating these findings in other settings.Seventh, although not the primary hypothesis in this study, in an effort to be as transparent as possible about how results in the present trial varied both across and within specific diagnoses, we reported means and between-condition effect sizes for diagnosis-specific outcomes in eTable 1 in the Supplement that accompanies our article.1 These data will be subject to further analyses.
No takes yet. Share an insight, caveat, or question.
A 2017 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: